[2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France]. - Franchet C; Djerroudi L; Maran-Gonzalez A; Abramovici O; Antoine M; Becette V; Berghian A; Blanc-Fournier C; Brabencova E; Charafe-Jauffret E; Chenard MP; Dauplat MM; et al. (Annales de pathologie, 2021)